Latest Breaking News On - Pfizer inc biontech - Page 1 : comparemela.com

Scientists hope mRNA tech is useful for other vaccines

When it became clear in early 2020 that the Sars-CoV-2 virus posed a pandemic threat, researchers who d been exploring using messenger RNA to develop vaccines saw an opportunity. Covid-19 shots made this way were the first to demonstrate efficacy, and they have proved to be the most effective vaccines against the disease. Two scientists whose research laid the groundwork for their development won the Nobel Prize in medicine Oct. 2. The performance of the vaccines, from Moderna Inc. and the Pfizer Inc./BioNTech SE partnership, has raised hopes among scientists that mRNA technology will prove useful against other diseases.

Pfizer-inc-biontech
Moderna-inc
Merck-co
Nobel-prize
Pfizer-inc

How Do mRNA Vaccines Work? What Else Can mRNA Technology Be Used for?

How Do mRNA Vaccines Work? What Else Can mRNA Technology Be Used for?
bloomberg.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bloomberg.com Daily Mail and Mail on Sunday newspapers.

Moderna-inc
Pfizer-inc-biontech
Nobel-prize
Pfizer-inc

Novavax needs 6 months to produce annual COVID shots that match new variants

By Leroy Leo (Reuters) - Novavax Inc said on Thursday it would require six months to produce a COVID-19 vaccine designed to match whichever coronaviru.

United-states
Bengaluru
Karnataka
India
Leroy-leo
Filip-dubovsky
Moderna-inc
Drug-administration
Pfizer-inc-biontech
Reuters
Novavax-inc
Chief-medical-officer-filip-dubovsky

Omicron sub-variant XBB.1.5 accounts for 61.3% of U.S. COVID cases

The Omicron subvariant XBB.1.5 has likely become the dominant variant in the United States, accounting for 61.3% of COVID cases in the week ended Jan. 28, data from the U.S. Centers for Disease.

Bengaluru
Karnataka
India
Shailesh-kuber
Khushi-mandowara
Raghav-mahobe
Krishna-chandra-eluri
Pfizer-inc-biontech

Omicron sub-variant XBB.1.5 accounts for 61.3% of U.S. COVID cases – CDC

(Reuters) - The Omicron subvariant XBB.1.5 has likely become the dominant variant in the United States, accounting for 61.3% of COVID cases in the wee.

United-states
Bengaluru
Karnataka
India
Shailesh-kuber
Khushi-mandowara
Raghav-mahobe
Krishna-chandra-eluri
Us-centers-for-disease
Reuters
Pfizer-inc-biontech
Disease-control